(Q45875821)

17 December 2017

title

Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry (English)

1 reference

17 December 2017

0 references

1 reference

S Haya

1

1 reference

17 December 2017

M F López

2

1 reference

17 December 2017

J A Aznar

3

1 reference

17 December 2017

J Batlle

4

1 reference

17 December 2017

Spanish Immune Tolerance Group

5

1 reference

17 December 2017

publication date

1 March 2001

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

154-159

1 reference

17 December 2017

Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcome

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Prevalence of factor IX inhibitors among patients with haemophilia B: results of a large-scale North American survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Tolerance induction using the Malmö treatment model 1982-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

The German National Immune Tolerance Registry, 1997 update. Study Group of German Haemophilia Centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

International immune tolerance registry, 1997 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00469.X

10.1046/J.1365-2516.2001.00469.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017